Market Research Logo

Compugen Ltd. - Product Pipeline Review - 2016

Compugen Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Compugen Ltd. - Product Pipeline Review - 2016’, provides an overview of the Compugen Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Compugen Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Compugen Ltd.
  • The report provides overview of Compugen Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Compugen Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Compugen Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Compugen Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Compugen Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Compugen Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Compugen Ltd. Snapshot
Compugen Ltd. Overview
Key Information
Key Facts
Compugen Ltd. - Research and Development Overview
Key Therapeutic Areas
Compugen Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Compugen Ltd. - Pipeline Products Glance
Compugen Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Compugen Ltd. - Drug Profiles
CGEN-15001
Product Description
Mechanism of Action
R&D Progress
CGEN-15021
Product Description
Mechanism of Action
R&D Progress
CGEN-15031
Product Description
Mechanism of Action
R&D Progress
CGEN-15051
Product Description
Mechanism of Action
R&D Progress
CGEN-15091
Product Description
Mechanism of Action
R&D Progress
CGEN-25009
Product Description
Mechanism of Action
R&D Progress
CGEN-856S
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit CGEN-15049 for Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit CGEN-15052 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit CGEN-15092 for Multiple Sclerosis
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 1 to Inhibit CGEN-15029 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 2 to Target B7/CD28 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 3 to Target B7/CD28 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 4 to Target B7/CD28 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody 5 to Target B7/CD28 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugate 2 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugates 1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody for Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit CGEN-15027 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target CGEN-928 for Multiple Myeloma
Product Description
Mechanism of Action
R&D Progress
Compugen Ltd. - Pipeline Analysis
Compugen Ltd. - Pipeline Products by Target
Compugen Ltd. - Pipeline Products by Molecule Type
Compugen Ltd. - Pipeline Products by Mechanism of Action
Compugen Ltd. - Recent Pipeline Updates
Compugen Ltd. - Dormant Projects
Compugen Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Compugen Ltd., Key Information
Compugen Ltd., Key Facts
Compugen Ltd. - Pipeline by Indication, 2016
Compugen Ltd. - Pipeline by Stage of Development, 2016
Compugen Ltd. - Monotherapy Products in Pipeline, 2016
Compugen Ltd. - Out-Licensed Products in Pipeline, 2016
Compugen Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Compugen Ltd. - Preclinical, 2016
Compugen Ltd. - Discovery, 2016
Compugen Ltd. - Pipeline by Target, 2016
Compugen Ltd. - Pipeline by Molecule Type, 2016
Compugen Ltd. - Pipeline Products by Mechanism of Action, 2016
Compugen Ltd. - Recent Pipeline Updates, 2016
Compugen Ltd. - Dormant Developmental Projects,2016
Compugen Ltd., Subsidiaries
List of Figures
Compugen Ltd. - Pipeline by Indication, 2016
Compugen Ltd. - Pipeline by Stage of Development, 2016
Compugen Ltd. - Monotherapy Products in Pipeline, 2016
Compugen Ltd. - Pipeline by Target, 2016
Compugen Ltd. - Pipeline by Molecule Type, 2016
Compugen Ltd. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report